About Euglena
Euglena is a company based in Tokyo (Japan) founded in 2005. The company has 897 employees as of December 31, 2024. Euglena operates in a competitive market with competitors including Microphyt, Olmix, Bioage, Provectus Algae and Aliga Microalgae, among others.
- Headquarter Tokyo, Japan
- Employees 897 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Euglena Co., Ltd.
-
Annual Revenue
$303.39 M (USD)2.44as on Dec 31, 2024
-
Net Profit
-$4.14 M (USD)75.5as on Dec 31, 2024
-
EBITDA
$24.85 M (USD)158.96as on Dec 31, 2024
-
Latest Funding Round
Not available
- Investors
-
Employee Count
897
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Euglena
Euglena is a publicly listed company on the TSE with ticker symbol 2931 in Japan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Euglena
Investors in Euglena
Euglena has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include SBI Investment.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital funds are managed to support unlisted companies' growth.
|
Locked | Locked | Locked |
Investor details for Euglena
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Euglena
Investment portfolio details for Euglena
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Euglena
Detailed financials for Euglena
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Euglena Comparisons
Peer comparison for Euglena
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Euglena
Euglena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Microphyt, Olmix, Bioage, Provectus Algae and Aliga Microalgae, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Microalgae cultivation technology is developed and supplied.
|
|
| Locked | Locked | Locked |
Developing and marketing algal extracts for use in plant, animal and human health products
|
|
| Locked | Locked | Locked |
Manufacturer of algal extracts nutritional products
|
|
| Locked | Locked | Locked |
Algae-based bio-products are produced using AI-driven technology.
|
|
| Locked | Locked | Locked |
Micro-algae are produced for food ingredients and dietary supplements.
|
Detailed competitors of Euglena
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Euglena
Complete news archive for Euglena
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Euglena
Euglena was founded in 2005 and raised its 1st funding round 1 year after it was founded.
Euglena is headquartered in Tokyo, Japan. It is registered at Tokyo, Tokyo, Japan.
As of Dec 31, 2024, the latest employee count at Euglena is 897.
Annual revenue of Euglena is $303.39M as on Dec 31, 2024.
Euglena was founded in 2005 and is headquartered in Tokyo, Japan. Operations center on the development and marketing of microalgae derived from the Euglena organism, a single-celled photosynthetic entity rich in nutrients essential for human survival. Efforts are directed toward addressing food security and environmental issues through its biological properties. The biotechnology sector is the primary focus, with no products marketed as of December 2016.
Euglena's top competitors include Microphyt, Provectus Algae and Olmix.
Yes, Euglena is publicly traded on TSE under the ticker symbol 2931.
Euglena has 1 investor. Key investors include SBI Investment.
The ticker symbol of Euglena is 2931 on TSE.